Provigil Helps Cancer Fatigue

Update from 2008 ASCO Meeting in Chicago Provigil® (modafinil) reduced fatigue in cancer patients receiving chemotherapy according to a study reported by Gary Morrow PhD at the 2008 ASCO meeting. Patients who were severely fatigued after their first chemotherapy treatment had less fatigue after they…

Read Full Post

KRAS Mutations Make a Difference In Response to Erbitux

Update from 2008 ASCO Meeting in Chicago Three studies reported during the 2008 American Society of Clinical Oncology found that colorectal cancer patients whose tumors have mutated KRAS genes do not benefit from treatment with the EGFR-inhibitor Erbitux® (cetuximab). At the same time, patients with…

Read Full Post

Calcium and Magnesium Infusions Reduce Neurotoxicity with Oxaliplatin

Update from 2008 ASCO Meeting in Chicago A study presented during the American Society of Clinical Oncology meeting showed that adding IV infusions of calcium and magnesium to oxaliplatin treatment reduced peripheral neuropathy. Eloxatin® (oxaliplatin) is part of the FOLFOX treatments for colorectal cancer.  As…

Read Full Post

Colorectal Cancer Focus on ASCO Second Day

Update from 2008 ASCO Meeting in Chicago Some thoughts from Kate Murphy. . . A very full day at ASCO.  I began with by stopping for juice and a muffin in the Advocates’ Lounge, which is a special service provided by ASCO through their programs…

Read Full Post

Cancer Specialists Meet at ASCO in Chicago

Update from 2008 ASCO Meeting in Chicago Some thoughts from Kate Murphy . . . I’m in Chicago for the 2008 American Society of Clinical Oncology meeting.  It’s huge!  More than 30,000 doctors and researchers from all over the world here to find out about…

Read Full Post
Page 3 of 3123